ESR1 and breast cancer: GSE (95% procyanidins) increases the efficacy of Dox in human breast cancer MCF-7, MDA-MB468, and MDA-MB231 cells suggesting a strong possibility of a synergistic effect of GSE and Dox combination, independent of the estrogen receptor status of cells [11].